Marqibo (liposomal vincristine) is a medication used to treat adults with a blood and bone marrow cancer called Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph- ALL). It's typically given if the cancer comes back or has gotten worse even after trying other anticancer medications. Marqibo (liposomal vincristine) has been discontinued and is no longer available in the United States.
Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph- ALL) in people whose cancer has returned or worsened after previous therapies
Marqibo (liposomal vincristine) is a vinca alkaloid. It works by binding to a protein called tubulin, which then slows or stops cancer cells from growing and spreading.
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.